AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Cartography of Social Cognition Network and Their Alterations in Patients With Epilepsy

RecruitingNAAges 18 Years - 65 YearsAllAssistance Publique - Hôpitaux de Paris
💬

In plain words

What the trial is, and whether it could suit you

Social cognition, which refers to the ability to interpret social information and behave accordingly in a social environment, is crucial in everyday life. But this ability has been shown to be altered in patients with epilepsy, especially in medial temporal lobe epilepsy, which leads to a deterioration in the patient's quality of life. However, the mechanisms of those deficiencies remain largely unknown. The Team objective is to achieve a structural and functional cartography of the social cognition network in 20 healthy subjects and 20 patients with drug-resistant medial temporal lobe epilepsy (before and one year after resective surgery of the epileptogenic focus). Social cognition deficiencies will be assessed using a specifically dedicated neuropsychological assessment validated in French (Batteries de Cognition Sociale BCS). Brain structural analyses will be performed on a 3-Tesla M

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion criteria: * Age ≥ 18 years old * Good understanding of written and verbal French language * Written consent signed by the subject * Patients with focal temporal lobe epilepsy for at least one year, drug-resistant, due to a hippocampal sclerosis * Undergoing presurgical assessment * Affiliated to a social security system Exclusion criteria: * Under juridical protection * With claustrophobia or any MRI contra-indication * Pregnancy or lactation * Participation in another research with an exclusion period * Refusal to be notified in the event of anomalies discovered during the performance of an MRI sequence
💊

What it tests

  • MRI 3T and MRI 7T
📍

Where

2 sites
NeuroSpin - CEA
Gif-sur-Yvette, France
Unité d'épilepsie - GHU Pitié Salpêtrière
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy